About Chiaro
Chiaro is a company based in London (United Kingdom) founded in 2013. It operates as a HealthTech. Chiaro has raised $1.8 million across 2 funding rounds. The company has 87 employees as of September 30, 2020. Chiaro offers products and services including Elvie. Chiaro operates in a competitive market with competitors including Atlantic Therapeutics, COSM, Elidah, Fizimed and PelviFly, among others.
- Headquarter London, United Kingdom
- Employees 87 as on 30 Sep, 2020
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chiaro Technology Ltd.
-
Annual Revenue
$223.92 K (USD)710as on Dec 31, 2023
-
Net Profit
$12.7 K (USD)4as on Dec 31, 2023
-
EBITDA
Not available
-
Total Equity Funding
$1.8 M (USD)
in 2 rounds
-
Latest Funding Round
$1.2 M (USD), Series A
May 01, 2014
-
Investors
Not available
-
Employee Count
87
as on Sep 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chiaro
Chiaro offers a comprehensive portfolio of products and services, including Elvie.
Innovative technology is developed for women's health improvement.
Funding Insights of Chiaro
Chiaro has successfully raised a total of $1.8M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.2 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Chiaro
Investment portfolio details for Chiaro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chiaro
Detailed financials for Chiaro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chiaro Comparisons
Peer comparison for Chiaro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chiaro
Chiaro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atlantic Therapeutics, COSM, Elidah, Fizimed and PelviFly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
|
| Locked | Locked | Locked |
Provider of devices for women pelvic floor disorder
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for pelvic floor muscle strengthening are offered.
|
|
| Locked | Locked | Locked |
Urinary leakage control devices are manufactured by Fizimed.
|
|
| Locked | Locked | Locked |
Pelvic floor muscle exercises are delivered via a mobile app.
|
Detailed competitors of Chiaro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chiaro
Complete news archive for Chiaro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chiaro
Chiaro was founded in 2013.
Chiaro is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Chiaro is a funded company, having raised a total of $1.8M across 2 funding rounds to date.
As of Sep 30, 2020, the latest employee count at Chiaro is 87.
Annual revenue of Chiaro is $223.92K as on Dec 31, 2023.
Chiaro is established as the parent company of Elvie, a brand focused on developing smarter technology for women. Solutions are created to improve womens lives through innovative health technology. The company operates within the HealthTech sector, targeting advancements in womens health and wellness.
Chiaro's top competitors include COSM, Fizimed and Atlantic Therapeutics.
Chiaro offers Elvie.